Related Experiment Video
Updated: May 29, 2026

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
Hypertensive Acute Heart Failure: An Evidence Based Approach
Mohamed Toufic El Hussein1, Alyssa Homan, Joseph Osuji C
1Author Affiliations: Faculty of Health, School of Nursing and Midwifery, Community & Education, Mount Royal University, Alberta, Canada; Faculty of Nursing, University of Alberta, Alberta, Canada; Acute Care Nurse Practitioner Medical Cardiology, Coronary Care Unit, Rockyview General Hospital, Alberta, Canada (Dr El Hussein); Department of Pediatrics, Alberta Health Services, Alberta, Calgary, Canada (Mrs Homan); and Faculty of Health, School of Nursing and Midwifery, Community, and Education, Mount Royal University, Calgary, AB, Canada (Dr Osuji).
Nurse practitioners can improve hypertensive acute heart failure (H-AHF) management by prioritizing vasodilators over diuretics and using advanced therapies like sequential nephron blockade and noninvasive ventilation for better patient outcomes.
Area of Science:
- Cardiology
- Nursing
- Pharmacology
Background:
- Hypertensive acute heart failure (H-AHF) presents unique management challenges.
- Traditional approaches focused on volume overload may not be optimal for H-AHF.
Purpose of the Study:
- To review current management strategies for H-AHF.
- To provide guidance for nurse practitioners in managing H-AHF.
Main Methods:
- Literature review of current approaches in H-AHF management.
- Emphasis on the shift in understanding congestion causes in H-AHF.
- Discussion of pharmacologic and non-pharmacologic interventions.
Main Results:
- Vascular redistribution is a key factor in H-AHF congestion, suggesting vasodilators as a primary treatment.
- Sequential nephron blockade and high-dose IV nitroglycerin show efficacy in diuretic resistance and pressure reduction.
- Noninvasive ventilation aids respiratory recovery in acute pulmonary edema.
Conclusions:
- Current H-AHF management strategies focus on vasodilators and advanced therapies.
- Further research is necessary to refine safety and efficacy in various clinical settings.
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure II: Pathophysiology
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure I: Introduction
Heart Failure VII: Nursing Interventions
Heart Failure VI: Adjunct Therapies
